Biography
Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.
Clinical interests / subspecialty
Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms
Education & training
Medical School: University of Miami Miller School of Medicine
Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine
Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)
Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)
Board certifications / licenses
- ABIM - Medical Oncology
- ABIM - Internal Medicine
Professional memberships
ASCO, AACR, ACP (Fellow)
Languages
English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)
Research areas
AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems
Clinical research experience
Phase I–III clinical trial leadership and portfolios across oncology networks
Leadership & recognition
- 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)
Publications & media
- 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
- PubMed
Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Arturo Loaiza-Bonilla
Cancer Urothélial : Symptômes, Stades, Méthodes de Traitement
JUNE 2025
Comprendre les Tumeurs Stromales Gastro-intestinales : Des Symptômes aux Taux de Survie
JUNE 2025
Myélofibrose Primitive : Causes, Symptômes et Options de Traitement
MAY 2025
L’importance des analyses de sang dans le diagnostic du myélome multiple
MAY 2025
Cancer du sein DCIS : ce que vous devez savoir sur le cancer de stade 0
MAY 2025
Symptômes du cancer du poumon de stade 1 : quand consulter un médecin
MAY 2025
Témoignages Réels : Comment j’ai découvert que j’avais un cancer du poumon
MAY 2025
Décryptage des taux de survie du cancer du poumon selon l’âge et le stade
MAY 2025
Qu’est-ce que la myélofibrose
MAY 2025
Cancer du sein inflammatoire au stade précoce : à quoi cela ressemble-t-il
MAY 2025
Symptômes rares du cancer du poumon que vous ne devez pas ignorer
MAY 2025
Comprendre le pronostic du myélome multiple : quels sont les facteurs les plus importants?
APRIL 2025
Comment la localisation de la tumeur influence le traitement du cancer du poumon à petites cellules
APRIL 2025
Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD !
APRIL 2025
Tumeur au Cerveau : Guide Simple pour Comprendre Votre Diagnostic
FEBRUARY 2025
Fibromes Utérins : Symptômes, Traitements et Options Médicales
FEBRUARY 2025
Métastases Osseuses: Symptômes et Options de Traitement
JANUARY 2025
Understanding Lung Adenocarcinoma: Symptoms and Treatments
JANUARY 2025
Adénocarcinome Pulmonaire : Symptômes, Traitements et Évolution
JANUARY 2025
Comment Prévenir le Cancer du Côlon : 5 Conseils Essentiels
DECEMBER 2024
J’ai guéri du cancer du pancréas
NOVEMBER 2024
Cancer Ovaire Symptome
OCTOBER 2024
Cancer Amygdale
OCTOBER 2024
Symptome Cancer Estomac
OCTOBER 2024